Najat Khan

Director & CEO and President

Director & CEO and President at RECURSION PHARMACEUTICALS, INC., filing insider transactions between 2026-03-09 and 2026-06-05.

Total Purchases

—

0 transactions

Total Sales

$179K

2 transactions

Companies Traded

2 total filings

Active Since

2026-03-09

Last: 2026-06-05

Companies

RECURSION PHARMACEUTICALS, INC.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-06-05	RXRX	Sale	23.6K	$3.58	$84K	2.18M	SEC ↗
2026-03-09	RXRX	Sale	28.3K	$3.35	$95K	2.26M	SEC ↗